AstraZeneca reveals COVID-19 vaccine sales but that isn’t why the stock is rising

AstraZeneca stock jumped 3.4% in early buying and selling on Friday, as the U.Ok.-Swedish drug firm reported better-than-expected earnings, led

Read more